Jorge Moll Describes How He Found His Life Path

Jorge Moll is a respected neuroscientist from Rio de Janeiro, Brazil. He attended the Federal University of Rio de Janeiro where he graduated with his medical degree in 1994. He continued his education and completed his neurology degree at the same University in 1997. His path to gain knowledge continued as he attended the University of Sao Paulo in 2004 and obtained his doctorate in the experimental physiopathology and physiology sciences. He has based his research and career on the neural bases of behavior and moral cognition, moral emotions and antisocial behaviors that some people experience. His desire to give back to society drove him to find the Cognitive and Behavioral Neuroscience Unit which helps people with neuropsychiatric disorders. He has grown and attracts patients from all over the world.

In a recent interview, Dr. Moll was asked what gave him his ideas and desire to journey on his life path. When asked where his idea for IDOR came from, he responded that he had a vision to promote innovative healthcare and education in his country of Brazil. His life path came from his passion and acting on it helped get him where he is now. In response to being asked where his personal inspiration and excitement comes from, Jorge Moll answered that cognitive systems and artificial intelligence have always been extremely intriguing to him. The way in which human brains work together with machines made him realize how he could improve healthcare and other major industries in the medical field. He also says that he is passionate and excited about the possibilities of gene therapy and regenerative medicine and what it could do for patients with brain damage.

Dr. Jorge Moll realizes that most innovative ideas, especially those in the neuroscience field can be met with hesitation. However by continuing to move forward and educate people, Moll and his team are able to more easily accomplish bigger high-risk projects, and help people at a global level. Moll won’t rest as long as he can continue helping patients with brain damage using innovative medicine that can help at a deeper level.